ARCHIVES

Funding opportunities listed.

This article is from The Cancer Letter archive.

Vol. 30 No. 36 | September 24, 2004

Download PDF Visit The Full Archive

Related Articles

Andrew von Eschenbach Sworn In As NCI Director.

January 25, 2002

Phase II Trial of BIND-014 Shows Anti-Tumor Activity in Q3W Arm

November 28, 2014

“What Is Good For NCI Is Good For NIH,” Broder Says In Address

January 13, 1995

Votrient Trial Meets PFS Endpoint In Epithelial Ovarian Cancer

June 28, 2013

International Cancer Genome Consortium Aims To Produce Data On 50 Cancer Types.

May 2, 2008

Ten-Year Breast Cancer Survival Improved In Past 60 Years, MD Anderson Study Finds

October 29, 2010